National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1754877

Government Disclaimer on use of this data



Case Details

VAERS ID: 1754877 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-15
Onset:2021-09-10
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Alanine aminotransferase, Aspartate aminotransferase, Blood alkaline phosphatase, Blood bilirubin, Cytomegalovirus test, Epstein-Barr virus test, Full blood count, Gamma-glutamyltransferase, HIV test, Hepatitis B virus test, Hepatitis C virus test, Hepatocellular injury, Lipase, Pain, Prothrombin time, Ultrasound scan, Vomiting
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Functional bowel syndrome; Goiter; Polycystic ovarian syndrome
Allergies:
Diagnostic Lab Data: Test Name: Alanine transaminase; Result Unstructured Data: Test Result:559 (10N); Test Name: Aspartate aminotransferase; Result Unstructured Data: Test Result:757 (20N); Comments: Cytolysis predominantly, decreasing compared to previous assessments; Test Name: alkaline phosphatase; Result Unstructured Data: Test Result:73; Test Name: Bilirubin; Result Unstructured Data: Test Result:Normal; Test Name: Cytomegalovirus; Test Result: Negative ; Test Name: Epstein-Barr virus; Test Result: Negative ; Test Name: Complete blood count; Result Unstructured Data: Test Result:Normal; Test Name: gamma GT; Result Unstructured Data: Test Result:111; Test Name: Hepatitis B Virus serology; Test Result: Negative ; Test Name: Hepatitis C Virus serology; Test Result: Negative ; Test Name: Human Immunodeficiency Virus serology; Test Result: Negative ; Test Name: Lipase; Result Unstructured Data: Test Result:19; Test Name: prothrombin time; Test Result: 110 %; Comments: Normal; Test Name: Ultrasound; Result Unstructured Data: Test Result:Normal liver size; Comments: no biliary tract abnormalities, no explanation for current symptomatology
CDC Split Type: FRPFIZER INC202101228937

Write-up: Post-vaccination pain; Hepatocellular injury; Belly ache; Vomiting; This is a spontaneous report from a contactable physician downloaded from the Regulatory Agency (RA)-WEB, regulatory authority number FR-AFSSAPS-NT20214022. A 34-years-old female patient received BNT162B2 (COMIRNATY, solution for injection), dose 2 intramuscular, administered in Arm Left on 15Aug2021 (Batch/Lot Number: Unknown) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included goitre, Polycystic ovarian syndrome, Functional bowel syndrome. The patient''s concomitant medications were not reported. On an unspecified date, It was reported patient had Post-vaccination pain prompted a work stoppage and the initiation of treatment by amitriptyline for a few days (dates of administration not known but administration at the end of Aug2021). On 10Sep2021, patient experienced Hepatocellular injury, Belly ache and vomiting. On 10Sep2021 (26 days after the vaccination), there was sudden onset of a hyperalgesic pain attack localised in the epigastrium transfixing to between the scapula and the right shoulder with favourable evolution in 30 minutes. Recurrence of two other hyperalgesic pain attacks in the evening, one of which with episodes of vomiting. The blood test found Aspartate aminotransferase 757 (20N), Alanine transaminase 559 (10N), gamma GT 111, alkaline phosphatase 73. Lipase at 19. Patient was admitted to the Emergency Room. Blood test was performed which showed Cytolysis predominantly at the Aspartate aminotransferase, decreasing compared to previous assessments, normal prothrombin time 101%, normal bilirubin. Normal complete blood count. Ultrasound showed Normal liver size, no biliary tract abnormalities, no explanation for current symptomatology. Viral serologies negative (Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Cytomegalovirus, Epstein-Barr virus). No autoimmune assessment performed. In summary, hepatocellular damage occurred 26 days after the 2nd dose of COMIRNATY. Incomplete aetiological assessment. At the time of this report the outcome of Vomiting and Post-vaccination pain was unknown, Belly ache recovered on an unknown date in 2021 and Hepatocellular injury was recovering. No follow-up attempts are possible. No further information expected. Information about batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-202101195781


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1754877


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166